Reflectocardiography (RCG): A leadless, optical reflection based facile measurement of human cardiac rhythm

AIP Advances ◽  
2022 ◽  
Vol 12 (1) ◽  
pp. 015113
Author(s):  
Arindam Kushagra ◽  
Uddipan Dasgupta ◽  
Srishti Roychowdhury ◽  
Srijani Samanta ◽  
Shivani Srivastava
1966 ◽  
Vol 210 (3) ◽  
pp. 505-508 ◽  
Author(s):  
AL Pinkerson ◽  
MH Luria ◽  
ED Freis
Keyword(s):  

Heart Rhythm ◽  
2021 ◽  
Vol 18 (8) ◽  
pp. S112
Author(s):  
Robert Przybylski ◽  
Molly Craig ◽  
Matthew Lippmann ◽  
Douglas Y. Mah ◽  
John K. Triedman ◽  
...  
Keyword(s):  

2021 ◽  
Vol 13 (1) ◽  
pp. 1-15
Author(s):  
Sho Shibita ◽  
Daisuke Hisano ◽  
Kazuki Maruta ◽  
Yu Nakayama ◽  
Ken Mishina ◽  
...  

2021 ◽  
Vol 147 ◽  
pp. 110942
Author(s):  
Diana J. Templos-Hernández ◽  
Luis A. Quezada-Téllez ◽  
Brian M. González-Hernández ◽  
Gerardo Rojas-Vite ◽  
José E. Pineda-Sánchez ◽  
...  

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
P Guedeney ◽  
J Silvain ◽  
F Hidden-Lucet ◽  
C Maupain ◽  
S Dinanian ◽  
...  

Abstract Background There are only limited options for long-term cardiac monitoring devices readily available in clinical practice for outpatients. Holter monitoring devices are limited by the uncomfort of wires and patches, the small number of leads for analysis, the quality of recordings or the monitoring duration while insertable cardiac monitors are costly and exposed to potential local complication. Purpose To describe a single center experience with a novel wearable device for cardiac rhythm monitoring. Methods The Cardioskin™ system is a patch-free, wire-free, wearable device with rechargeable batteries that provides a high quality 15-lead electrocardiogram monitoring over 1 month (Figure 1). Data are sent using a mobile application downloaded in the patient smartphone to a central Corelab where they can be interpreted by an expert and/or the prescribing physician. An alarm signal is readily available within the Cardioskin™ device, to allow patients to indicate the presence of symptoms. In this single center retrospective registry, we provide a first report of the use of this novel device in real world practice, with indication and duration of cardiac monitoring left at the physicans “discretion”. Results From January 2019 to December 2019, the Cardioskin™ system was prescribed in 60 patients for an overall median duration of 26.5 (14–32) days. The mean age of the patients was 45±12.2 years and 24 (40%) were male. Indications for cardiac monitoring were post-Stroke, palpitation, syncope and cardiomyopathy assessment in 56%, 30%, 7% and 7% of the cases, respectively. A sustained (>30 seconds) supraventricular tachycardia was detected in 4 cases, including one case of atrial fibrillation, two case of atrial tachycardia and on case of junctional tachycardia. Unsustained ventricular tachycardia and atrial fibrillation burst were detected in another 2 cases (Figure 1). There was no reported case of skin irritation by the Cardioskin™ system or abrupt interruption of the monitoring by the patients. Conclusion The Cardioskin™ system is a novel, discreet and comfortable cardiac rhythm wearable long-term monitoring device which can be used in clinical practice for broad diagnostic indications. Figure 1. Cardioskin system Funding Acknowledgement Type of funding source: Public Institution(s). Main funding source(s): ACTION coeur


Children ◽  
2021 ◽  
Vol 8 (5) ◽  
pp. 421
Author(s):  
Lukas Peter Mileder ◽  
Nicholas Mark Morris ◽  
Stefan Kurath-Koller ◽  
Jasmin Pansy ◽  
Gerhard Pichler ◽  
...  

An asphyxiated term neonate required postnatal resuscitation. After six minutes of cardio-pulmonary resuscitation (CPR) and two doses of epinephrine, spontaneous circulation returned, but was shortly followed by ventricular fibrillation. CPR and administration of magnesium, calcium gluconate, and sodium bicarbonate did not improve the neonate’s condition. A counter shock of five Joule was delivered and the cardiac rhythm immediately converted to sinus rhythm. The neonate was transferred to the neonatal intensive care unit and received post-resuscitation care. Due to prolonged QTc and subsequently suspected long-QT syndrome propranolol treatment was initiated. The neonate was discharged home on day 14 without neurological sequelae.


Sign in / Sign up

Export Citation Format

Share Document